We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
Cap. Flow
-$6.76B
Cap. Flow %
-444.29%
Top 10 Hldgs %
100%
Holding
929
New
Increased
6
Reduced
3
Closed
920

Sector Composition

Rank Sector Weight
1 Technology 45.54%
2 Healthcare 36.97%
3 Financials 14.43%
4 Communication Services 3.06%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGR
651
DELISTED
Kimbell Tiger Acquisition Corporation
TGR
-275,741
Closed -$2.8M
BRIV
652
DELISTED
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
-165,166
Closed -$1.62M
VLAT
653
DELISTED
Valor Latitude Acquisition Corp. Class A Ordinary Shares
VLAT
-463,105
Closed -$4.57M
ADALW
654
DELISTED
Anthemis Digital Acquisitions I Corp Warrant
ADALW
-112,381
Closed -$13K
ADAL
655
DELISTED
Anthemis Digital Acquisitions I Corp Class A Ordinary Shares
ADAL
-515,140
Closed -$5.2M
BBBY
656
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
-325,700
Closed -$1.09M
TRAQ.WS
657
DELISTED
Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRAQ.WS
-459,569
Closed -$55K
TRAQ
658
DELISTED
Trine II Acquisition Corp.
TRAQ
-1,670,363
Closed -$16.7M
CIIG
659
DELISTED
CIIG Capital Partners II, Inc. Class A Common Stock
CIIG
-572,695
Closed -$5.7M
ORIA
660
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
-237,693
Closed -$2.34M
SKYA
661
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
-161,980
Closed -$1.6M
CSII
662
DELISTED
Cardiovascular Systems, Inc.
CSII
-45,403
Closed -$629K
IQMD
663
DELISTED
Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
-381,797
Closed -$3.85M
HZON
664
DELISTED
Horizon Acquisition Corporation II
HZON
-464,113
Closed -$4.64M
HZON.WS
665
DELISTED
Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HZON.WS
-233,880
Closed -$33K
NHIC
666
DELISTED
NewHold Investment Corp. II Class A Common Stock
NHIC
-1,732,500
Closed -$17.1M
NHICW
667
DELISTED
NewHold Investment Corp. II Warrant
NHICW
-891,915
Closed -$49K
IPVI
668
DELISTED
InterPrivate IV InfraTech Partners Inc. Class A Common Stock
IPVI
-522,636
Closed -$5.15M
TIOA
669
DELISTED
Tio Tech A Class A Ordinary Share
TIOA
-715,870
Closed -$7.08M
YTPG
670
DELISTED
TPG Pace Beneficial II Corp.
YTPG
-951,516
Closed -$9.31M
TCVA
671
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
-239,291
Closed -$2.35M
GEEX
672
DELISTED
Games & Esports Experience Acquisition Corp. Class A Ordinary Shares
GEEX
-467,907
Closed -$4.75M
GEEXW
673
DELISTED
Games & Esports Experience Acquisition Corp. Warrants
GEEXW
-233,953
Closed -$30K
AMYT
674
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
-2,000,000
Closed -$13.8M
REVE
675
DELISTED
Alpine Acquisition Corp
REVE
-143,174
Closed -$1.47M

Similar funds

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.

  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
  • UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
  • UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.